These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3158107)

  • 1. The differential inhibitory effects exerted by cyclosporine and hydrocortisone on the activation of human cytotoxic lymphocytes by recombinant interleukin-2 versus allospecific CTL.
    Grimm EA; Muul LM; Wilson DJ
    Transplantation; 1985 May; 39(5):537-40. PubMed ID: 3158107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.
    Mulé JJ; Schwarz SL; Roberts AB; Sporn MB; Rosenberg SA
    Cancer Immunol Immunother; 1988; 26(2):95-100. PubMed ID: 2452015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
    Muul LM; Gately MK
    J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
    J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR; Sassenfeld HM; Widmer MB
    J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional studies on the precursors of human lymphokine-activated killer cells.
    Gray JD; Shau HY; Golub SH
    Cell Immunol; 1985 Dec; 96(2):338-50. PubMed ID: 3939293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of intragraft interleukin-2-activated killer cells and allospecific cytolytic T lymphocytes in rejecting lung allografts.
    Norin AJ; Kamholz SL
    Transplantation; 1989 Nov; 48(5):856-62. PubMed ID: 2530670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantation.
    Uberti J; Martilotti F; Chou TH; Kaplan J
    Blood; 1992 Jan; 79(1):261-8. PubMed ID: 1370206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral blood lymphocytes.
    Grimm EA; Wilson DJ
    Cell Immunol; 1985 Sep; 94(2):568-78. PubMed ID: 3928175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine.
    Noble RL; Steinmuller D
    Transplantation; 1989 Feb; 47(2):322-6. PubMed ID: 2784016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lethal irradiation and cyclosporin A treatment on the growth and tumoricidal activity of a T cell clone potentially useful in cancer therapy.
    Cesano A; Visonneau S; Cioé L; Clark SC; Santoli D
    Cancer Immunol Immunother; 1995 Mar; 40(3):139-51. PubMed ID: 7728772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporine on secondary cytotoxic T lymphocyte responses.
    Kiziroglu F; Miller RG
    Transplantation; 1990 May; 49(5):961-5. PubMed ID: 2139987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.